Chemoinformaics analysis of 2,4-Dimethyldodecane
| Molecular Weight | 198.394 | nRot | 9 |
| Heavy Atom Molecular Weight | 168.154 | nRig | 0 |
| Exact Molecular Weight | 198.235 | nRing | 0 |
| Solubility: LogS | -6.804 | nHRing | 0 |
| Solubility: LogP | 6.808 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 43.3838 |
| nHD | 0 | BPOL | 30.0962 |
| QED | 0.434 |
| Synth | 2.311 |
| Natural Product Likeliness | 0.761 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.01 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.43 |
| MDCK | 0.00000926 |
| BBB | 0.407 |
| PPB | 0.978471 |
| VDSS | 3.091 |
| FU | 0.022375 |
| CYP1A2-inh | 0.62 |
| CYP1A2-sub | 0.215 |
| CYP2c19-inh | 0.527 |
| CYP2c19-sub | 0.568 |
| CYP2c9-inh | 0.397 |
| CYP2c9-sub | 0.943 |
| CYP2d6-inh | 0.047 |
| CYP2d6-sub | 0.037 |
| CYP3a4-inh | 0.179 |
| CYP3a4-sub | 0.113 |
| CL | 6.987 |
| T12 | 0.098 |
| hERG | 0.051 |
| Ames | 0.004 |
| ROA | 0.029 |
| SkinSen | 0.889 |
| Carcinogencity | 0.039 |
| EI | 0.968 |
| Respiratory | 0.305 |
| NR-Aromatase | 0.006 |
| Antiviral | Yes |
| Prediction | 0.741644 |